Related Experiment Video
Updated: Jun 28, 2026

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
Concurrent chemoradiotherapy for primary cervical spinal cord germinoma
Ka-Yen Yang1, Shau-Hsuan Li, Jui-Wei Lin
1Department of Neurosurgery, Chang Gung Memorial Hospital - Kaohsiung Medical Center, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung 833, Taiwan.
A rare cervical spinal cord germinoma in a 39-year-old woman was successfully treated with biopsy and concurrent chemoradiotherapy. The patient achieved disease-free status and neurological recovery, marking a unique case in medical literature.
Area of Science:
- Neuro-oncology
- Spinal Cord Neoplasms
- Germ Cell Tumors
Background:
- Primary intramedullary germinomas of the spinal cord are exceptionally rare, with only a few documented cases.
- Intramedullary germinomas typically occur in younger patients and often involve the brain.
Observation:
- A 39-year-old woman presented with a primary intramedullary germinoma in the cervical spinal cord.
- The patient had no evidence of intracranial or disseminated germ cell tumors.
Findings:
- The patient underwent biopsy followed by concurrent chemoradiotherapy, a treatment regimen not previously reported for this condition.
- Histological confirmation of primary intramedullary cervical spinal cord germinoma was established.
- At 20-month follow-up, the patient was disease-free with significant resolution of pre-operative neurological deficits.
Implications:
- This case highlights the potential efficacy of concurrent chemoradiotherapy for primary spinal cord germinomas.
- It expands the understanding of germinoma presentation and treatment in adults.
- The successful outcome suggests a potential therapeutic avenue for similar rare spinal cord tumors.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Treatment Resistent Cancers
Treatment Resistant Cancers
